|
|
ABCD
NATIONWIDE EXENATIDE AUDIT |
|
Papers, abstracts,
presentations, posters and webcasts emanating from the audit |
|
|
|
Webcast |
Webcast of ABCD liraglutide and exenatide
audits research fellow, Dr Ken Thong, presenting his paper at the EASD in
Stockholm, September 22, 2010:
Response at 3 months to insulin dose decisions made at exenatide initiation
in the Association of British Clinical Diabetologists (ABCD) nationwide
exenatide audit |
|
|
Webcast of former ABCD liraglutide and
exenatide audits research fellow, Dr Ken Thong, presenting his paper at the
IDF in Dubai, December 6, 2011:
Differences in response between exenatide and liraglutide in the Association
of British Clinical Diabetologists (ABCD) nationwide audits |
|
|
|
Published papers |
|
Ryder, R.E.J., Thong, K.Y., Cull, M.L., Mills,
A.P., Walton, C., Winocour, P.H., on behalf of the ABCD nationwide exenatide
audit contributors. The Association of British Clinical Diabetologists (ABCD)
nationwide exenatide audit. |
Practical Diabetes International 2010; 27(8): 352-357
Full paper (ABCD members and audit contributors only):
Practical Diabetes International 2010; 27(8): 352-357 |
All contributors are listed |
|
|
|
K. Y. Thong, B. Jose, N. Sukumar, M. L. Cull,
A. P. Mills, T. Sathyapalan, W. Shafiq, A. S. Rigby, C. Walton, R. E. J.
Ryder, on behalf of the ABCD nationwide exenatide audit contributors.
Safety, efficacy and tolerability of exenatide in combination with insulin
in the Association of British Clinical Diabetologists (ABCD) nationwide
exenatide audit. |
Diabetes, Obesity and Metabolism 2011; 13(8): 703-710
Full paper (ABCD members and audit contributors only):
Diabetes, Obesity and Metabolism 2011; 13(8): 703-710
|
All contributors are listed |
|
|
|
K.Y. Thong, B. Jose, A.D. Blann, M.L. Cull,
A.P. Mills, T. Sathyapalan, C. Walton, and R.E.J. Ryder, on behalf of the
ABCD nationwide exenatide audit contributors. Response at 3 months to
insulin dose decisions made at exenatide initiation in the Association of
British Clinical Diabetologists (ABCD) nationwide exenatide audit. |
Diabetes Res Clin Pract. 2011; 93(2): e87-e91
Full paper (ABCD members and audit contributors only):
Diabetes Res Clin Pract. 2011; 93(2): e87-e91 |
All contributors are listed |
|
|
|
K.Y. Thong, M.L. Cull, R.E.J. Ryder, C.
Walton, on behalf of the ABCD nationwide exenatide and liraglutide audit
contributors. Insulin avoidance and treatment outcomes among patients with a
professional driving licence starting glucagon-like peptide 1 (GLP-1)
agonists in the Association of British Clinical Diabetologists (ABCD)
nationwide exenatide and liraglutide audits. |
Diabetic Medicine 2012; 29(5): 690-692
Full paper (ABCD members and audit contributors only):
Diabetic Medicine 2012; 29(5): 690-6921
|
All contributors are listed |
|
|
|
Bob Ryder and Ken Thong, on behalf of the ABCD
nationwide exenatide and nationwide liraglutide audit contributors. Findings
from the Association of British Clinical Diabetologists (ABCD) nationwide
exenatide and liraglutide audits. |
|
In Hot topics in diabetes, 5th edition, Vora J, ed. Synergy, London, 2012:
49-61 |
|
|
All contributors are listed |
|
|
|
Ryder REJ, Thong KY, on behalf of the ABCD
nationwide exenatide audit contributors. Incidence of acute pancreatitis in
the Association of British Clinical Diabetologists (ABCD) nationwide
exenatide audit. |
|
Epub 30 June 2013.
|
All contributors are listed |
|
|
|
KY Thong, REJ Ryder. Was it really pancreatitis from GLP-1 receptor agonist
therapy? |
Practical Diabetes 2013; 30(8): 310
Full paper (ABCD members and audit contributors only):
Practical Diabetes 2013; 30(8): 310
|
All contributors are listed |
|
|
|
R. E. J. Ryder, P. Sen Gupta, K. Y. Thong on
behalf of the ABCD nationwide exenatide and liraglutide audit contributors.
The Association of British Clinical Diabetologists nationwide exenatide and
liraglutide audits suggest a low incidence of acute pancreatitis. Response
to Robson. Incretins and pancreatitis—what happens next? A personal
viewpoint |
Diabetic Medicine 2013; 30(12): 1510-1511
Full paper (ABCD members and audit contributors only):
Diabetic Medicine 2013; 30(12): 1510-1511
|
All contributors are listed
|
|
|
|
KY Thong, P Sen Gupta, ML Cull, KA Adamson, DS
Dove, SV Rowles, S Tarpey, C Duncan, J Chalmers, R Harper, P McDonald, U
Brennan, C Walton, REJ Ryder on behalf of the ABCD nationwide exenatide and liraglutide
audit contributors. NICE guidelines versus clinical practice – GLP-1
receptor agonists in type 2 diabetes |
Br J Diabetes Vasc Dis 2014; 14: 52-59
Full paper:
Br J Diabetes Vasc Dis 2014; 14: 52-59 |
All contributors are listed
|
|
|
|
Slides from presentations (members and
audit contributors only) |
|
DUK satellite symposium, Glasgow, March 10,
2009 |
|
ABCD Spring meeting, Bristol, May 8, 2009 |
|
DUK satellite symposium, Liverpool, March 2,
2010 (Response at 6 months) |
|
DUK annual professional conference, Liverpool,
March 3, 2010 (Response with time) |
|
ABCD Spring meeting, Newcastle, May 7, 2010 (With insulin)) |
|
EASD Stockholm ,September 22, 2010 |
|
DUK annual professional conference, London,
April 1, 2011 |
|
ADA Scientific Update
Satellite Meeting, San Diego, June 26 2011 |
|
ADS/ADEA Annual
Scientific Meeting, Perth, August 31, 2011 |
|
EASD Scientific Update
Satellite Meeting, Lisbon, September 14 2011 |
|
IDF Scientific Update
Satellite Meeting, Dubai, December 6 2011 |
|
IDF Main Meeting,
Dubai, December 6 2011 |
|
|
|
Abstracts |
|
EASD Vienna 2009: R.E.J. Ryder,
C. Walton, P.H. Winocour, ABCD nationwide exenatide audit contributors.
Association of British Clinical Diabetologists (ABCD) nationwide exenatide
audit. Diabetologia 2009, Vol.52 Supplement1: A741 |
|
IDF Montreal 2009:
R.E.J. Ryder, C. Walton, P.H.
Winocour, ABCD nationwide exenatide audit contributors. Factors accounting
for variability in weight and HbA1c response to exenatide in the Association
of British Clinical Diabetologists (ABCD) nationwide exenatide audit.
Abstract Book, 20th World Diabetes Congress, IDF, Montreal, Canada, 18-22
October 2009, pp.582 |
|
EASD
Stockholm 2010: K.Y. Thong, R.E.J. Ryder, B. Jose, S. Thozhukat, W.
Shafiq, A. Rigby, C. Walton, ABCD nationwide exenatide audit contributors.
Response at 3 months to insulin dose decisions made at exenatide initiation
in the Association of British Clinical Diabetologists (ABCD) nationwide
exenatide audit . Diabetologia 2010, Vol.53 Supplement1: S38 |
|
EASD Stockholm 2010: B. Jose, R.E.J. Ryder, K.Y. Thong, S. Thozhukat, W.
Shafiq, ABCD nationwide exenatide audit contributors. Safety and efficacy of
using exenatide in combination with insulin in the Association of British
Clinical Diabetologists (ABCD) nationwide exenatide audit. Diabetologia 2010, Vol.53 Supplement1:
S343 |
|
ABCD Autumn Meeting, London, 2010: K.Y. Thong, B. Jose, N. Sukumar, M.L.
Cull, A.P. Mills, T. Sathyapalan, W. Shafiq, A. Rigby, C. Walton, R.E.J.
Ryder, on behalf of the ABCD nationwide exenatide audit contributors. 16.6%
(1 in 6) patients who continued insulin at the time of exenatide start came
off insulin in the Association of British Clinical Diabetologists (ABCD)
Nationwide Exenatide Audit. Poster 5, ABCD Autumn Meeting 2010 |
|
ABCD Autumn Meeting, London, 2010: R.E.J. Ryder, K.Y. Thong, M.L. Cull,
A.P. Mills, C. Walton, K.A. Adamson, D.S. Dove, on behalf of the ABCD
nationwide exenatide audit contributors. Problems with the NICE guideline
for exenatide exposed in the Association of British Clinical Diabetologists
(ABCD) nationwide exenatide audit. Poster 7, ABCD Autumn Meeting 2010 |
|
Australian Diabetes
Society 2011: Ken Y Thong and Bob Ryder on behalf of the ABCD nationwide
exenatide and liraglutide audits contributors. Response of HbA1c and weight
against time in the Association of British Clinical Diabetologists (ABCD)
nationwide exenatide and liraglutide audits. 2011 ADS/ADEA Annual Scientific
Meeting Programme, Abstract 062 |
EASD Lisbon
2011: R.E.J. Ryder, K.Y. Thong, M.L. Cull, A.P. Mills, C. Walton, ABCD
nationwide
exenatide and liraglutide audit contributors. The Association of British
Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audits. Diabetologia 2011, Vol.54 Supplement1:
S326 |
EASD Lisbon
2011: C. Walton, R.E.J. Ryder, M.L. Cull, A.P. Mills, K.Y. Thong, ABCD
nationwide
exenatide and liraglutide audit contributors. Factors associated with HbA1c
and weight changes at 6 months in theAssociation of British Clinical
Diabetologists (ABCD) nationwide exenatide and liraglutide audits. Diabetologia 2011, Vol.54 Supplement1:
S326 |
|
ABCD Autumn Meeting, London, 2011: CE Walton, REJ Ryder, ML Cull, AP
Mills, KY Thong, , on behalf othe ABCD nationwide exenatide and liraglutide
audit contributors. Factors associated with HbA1c and weight changes at 6
months in Association of British Clinical Diabetologists (ABCD) nationwide
exenatide and liraglutide audit. Poster 4a, ABCD Autumn Meeting 2011 |
|
ABCD Autumn Meeting, London, 2011: REJ Ryder, KY Thong, ML Cull, A P
Mills C Walton. The Association of British Clinical Diabetologists (ABCD)
nationwide exenatide and liraglutide audits. Poster 4b, ABCD Autumn Meeting
2011 |
IDF
Dubai 2011: R.E.J. Ryder, K.Y. Thong, M.L. Cull, A.P. Mills, C. Walton,
ABCD nationwide exenatide and liraglutide audit contributors. Differences in
response between exenatide and liraglutide in the Association of British
Clinical Diabetologists (ABCD) nationwide audits
Abstract Book, 21st World Diabetes Congress, IDF, Dubai, UAE, 4-8 December
2011. (oral presentation) |
IDF
Dubai 2011: K. Thong, K. Darzy, M.L. Cull, A.P. Mills, R.E.J. Ryder,
ABCD nationwide
exenatide and liraglutide audit contributors. Switching exenatide or
gliptins to liraglutide in the Association of British Clinical
Diabetologists (ABCD) nationwide liraglutide audit
Abstract Book, 21st World Diabetes Congress, IDF, Dubai, UAE, 4-8 December
2011. (poster presentation) |
IDF
Dubai 2011: K. Thong, R.E.J. Ryder, C. Walton, ABCD nationwide exenatide
and liraglutide audit contributors. Factors associated with HbA1c and weight
changes in the Association of British Clinical Diabetologists nationwide
GLP-1 agonists audits.
Abstract Book, 21st World Diabetes Congress, IDF, Dubai, UAE, 4-8 December
2011. (poster presentation) |
|
IDF
Melbourne 2013: K.Y. Thong, P. Sen Gupta, R.E.J. Ryder, ABCD nationwide exenatide
and liraglutide audit contributors. The efficacy of exenatide and
liraglutide among South Asians in the Association of British Clinical
Diabetologists nationwide audits.
Abstract Book, 22nd World Diabetes Congress, IDF, Melbourne, Australia, 2-6 December
2013. (poster presentation) |
|
ABCD
Spring Meeting, Edinburgh, 2014, abstract 1: KY Thong, P Sen
Gupta, ML Cull, KA Adamson, DS Dove, SV Rowles, S Tarpey, C Duncan, J
Chalmers, R Harper, P McDonald, U Brennan, C Walton, REJ Ryder on behalf of the ABCD nationwide
exenatide and liraglutide
audit contributors. NICE guidelines versus clinical practice – GLP-1
receptor agonists in type 2 diabetes: the ABCD nationwide audits. Poster 1, ABCD Spring Meeting 2014 |
|
|
|
Posters (members and audit contributors
only) |
|
EASD Vienna 2009 |
|
IDF Montreal 2009 |
|
EASD
Stockholm 2010 |
|
ABCD London
Autumn 2010a |
|
ABCD London Autumn 2010b |
|
EASD Lisbon 2011a |
|
EASD
Lisbon 2011b |
|
ABCD London
Autumn 2011a |
|
ABCD London Autumn 2011b |
|
IDF Dubai 2011a |
|
IDF Dubai 2011b |
|
IDF
Melbourne 2013 |
|
ABCD
Edinburgh Spring 2014 |
|
|
|
The ABCD nationwide
exenatide audit is an independent audit supported by an unrestricted grant
from Eli Lilly Ltd |
|
